Presentation is loading. Please wait.

Presentation is loading. Please wait.

Dual antiplatelet therapy is associated with prolonged survival after lower extremity revascularization  Peter A. Soden, MD, Sara L. Zettervall, MD, MPH,

Similar presentations


Presentation on theme: "Dual antiplatelet therapy is associated with prolonged survival after lower extremity revascularization  Peter A. Soden, MD, Sara L. Zettervall, MD, MPH,"— Presentation transcript:

1 Dual antiplatelet therapy is associated with prolonged survival after lower extremity revascularization  Peter A. Soden, MD, Sara L. Zettervall, MD, MPH, Klaas H.J. Ultee, BSc, Bruce E. Landon, MD, MBA, A. James O'Malley, PhD, Philip P. Goodney, MD, MS, Randall R. DeMartino, MD, MS, Shipra Arya, MD, Marc L. Schermerhorn, MD  Journal of Vascular Surgery  Volume 64, Issue 6, Pages e1 (December 2016) DOI: /j.jvs Copyright © 2016 Society for Vascular Surgery Terms and Conditions

2 Fig Cumulative adjusted survival for patients with critical limb ischemia (CLI) undergoing (A) bypass and (B) endovascular intervention. ASA, Aspirin; CI, confidence interval; DAPT, dual antiplatelet therapy; HR, hazard ratio. Journal of Vascular Surgery  , e1DOI: ( /j.jvs ) Copyright © 2016 Society for Vascular Surgery Terms and Conditions

3 Supplementary Fig (online only)
Cumulative adjusted survival for patients undergoing (A) bypass and (B) endovascular intervention. ASA, Aspirin; CI, confidence interval; DAPT, dual antiplatelet therapy; HR, hazard ratio. Journal of Vascular Surgery  , e1DOI: ( /j.jvs ) Copyright © 2016 Society for Vascular Surgery Terms and Conditions


Download ppt "Dual antiplatelet therapy is associated with prolonged survival after lower extremity revascularization  Peter A. Soden, MD, Sara L. Zettervall, MD, MPH,"

Similar presentations


Ads by Google